Teladoc’s revenue and patient visits this year show it isn’t a pandemic-only stock. Vertex plans to file for regulatory approval next year of a potentially game-changing blood disorder candidate. Etsy’s recent acquisitions should help it to expand its reach and grow in the coming years. A lot can happen in…
